Oncternal Therapeutics (ONCT) Stock Chart & Stock Price History $1.14 +0.06 (+5.56%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Oncternal Therapeutics Stock Price Performance 5 Day Performance-3.69%1 Month Performance-23.49%3 Month Performance-75.66%6 Month Performance-87.23%Year-To-Date Performance-89.76%1 Year Performance-83.75% Receive ONCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! ONCT Stock Chart for Wednesday, November, 20, 2024 ONCT Chart by TradingView Oncternal Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/19/2024$1.07$1.08+0.93%$1.08$1.0351,846 shs$3.17 million11/18/2024$1.14$1.07-6.14%$1.13$1.0721,313 shs$3.17 million11/15/2024$1.11$1.14+2.70%$1.22$1.0761,780 shs$3.37 million11/14/2024$1.14$1.11-2.55%$1.20$1.1131,632 shs$3.29 million11/13/2024$1.21$1.14-5.87%$1.30$1.03238,990 shs$3.37 million11/12/2024$1.29$1.21-6.20%$1.27$1.17106,726 shs$3.58 million Get the Latest News and Ratings for ONCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/11/2024$1.27$1.29+1.57%$1.33$1.2584,059 shs$3.82 million11/08/2024$1.37$1.27-7.30%$1.46$1.25122,932 shs$3.76 million11/07/2024$1.72$1.37-20.35%$1.71$1.26288,260 shs$4.06 million11/06/2024$1.62$1.72+6.17%$1.74$1.5569,838 shs$5.09 million11/05/2024$1.48$1.62+9.46%$1.68$1.50136,919 shs$4.80 million11/04/2024$1.50$1.48-1.33%$1.53$1.4433,846 shs$4.38 million11/01/2024$1.46$1.50+2.74%$1.64$1.4372,857 shs$4.44 million10/31/2024$1.50$1.46-2.67%$1.56$1.41110,158 shs$4.32 million10/30/2024$1.53$1.50-1.96%$1.60$1.4845,444 shs$4.44 million10/29/2024$1.44$1.53+6.25%$1.77$1.43187,755 shs$4.53 million10/28/2024$1.49$1.44-3.36%$1.53$1.4053,290 shs$4.26 million10/25/2024$1.49$1.49$1.54$1.4718,286 shs$4.41 million10/24/2024$1.68$1.49-11.31%$1.71$1.47124,547 shs$4.41 million10/23/2024$1.71$1.68-1.75%$1.80$1.5985,810 shs$4.97 million10/22/2024$2.09$1.71-18.18%$2.01$1.65246,877 shs$5.06 million10/21/2024$1.44$2.09+45.64%$2.37$1.491.00 million shs$6.19 million Related Companies PMCB Stock Price Chart AIM Stock Price Chart NLSP Stock Price Chart SNSE Stock Price Chart WENA Stock Price Chart SLGL Stock Price Chart TLPH Stock Price Chart AWH Stock Price Chart IPA Stock Price Chart NKGN Stock Price Chart Receive ONCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ONCT) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredWhy Buffett, Bezos & Congress Are Rushing Into This SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncternal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncternal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.